COMFORT Study: A Crossover Study of NeoRecormon (Epoetin Beta) and Darbepoetin Alfa in Patients With Renal Anemia.
Condition: AnemiaInterventions: Drug: darbepoetin alfa; Drug: epoetin beta [NeoRecormon]Sponsor: Hoffmann-La RocheCompleted - verified January 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials